HIV drug could treat Alzheimer’s, age-associated disorders

Research led by Brown faculty members John Sedivy, Marco De Cecco, Nicola Neretti, and Stephen Helfand found that blocking retrotransposon activity with a generic HIV/AIDS medication significantly reduces age-related inflammation in old mice and senescent human cells, providing hope for treating age-associated disorders.  Article.  The results were published in Nature February 5,2019  [Nature,volume 566, pages 73–78 (2019)].